Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
HCV: early-phase trial registry
3 of 9 indexed HCV trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,916 of 28,707 conditions by registered trial count.
9 US clinical trials · 3 currently recruiting · #1,916 of 28,707 conditions by registered trial count
HCV: 9 US clinical trials tracked, 3 recruiting.
HCV is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is North Jersey AIDS Alliance dba North Jersey Community Research Initiative (NJCRI), running 1 of these trials.
Enrollment posture brief
Registry condition hcv
OPEN 3 | RECR 33% | LATE 0 | EARLY 2 | RANK #1916 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
HCV lists 3 open slots (33% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for HCV on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
HCV is recruiting below its size-band peers.
3 of 9 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of HCV trials is spread across many organizations.
North Jersey AIDS Alliance dba North Jersey Community Research Initiative (NJCRI) accounts for 1 of 9 trials (11.1%). 9 distinct sponsors appear on at least one study for this condition label.
-
Typical HCV enrolment sits around 141 participants.
Median target enrolment is 141 among the 9 trials that report a genuine target (sentinel values excluded). 3 of those (33.3%) plan for fewer than 100 participants.
-
HCV research is mostly interventional.
7 interventional and 2 observational studies make up this index (77.8% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
9 total, page 1 of 1
A Setting Focus Overdose Prevention Intervention
Johns Hopkins Bloomberg School of Public Health
NCT05320835
Appalachian Partnership to Reduce Disparities (Aim 2)
Wake Forest University Health Sciences
NCT04378439
Prophylaxis With Direct-acting Antivirals for Kidney Transplantation From HCV-Infected Donors to Uninfected Recipients
Johns Hopkins University
NCT05653232
Integrated HIV Prevention and HCV Care for PWID
Columbia University
NCT03981445
Hepatitis C Treatment to Prevent HIV, Initiate Opioid Substitution Therapy, and Reduce Risky Behavior
University of Maryland, Baltimore
NCT03221309
The Ganchero Intervention for Migrant People Who Inject Drugs From Puerto Rico in New York City
North Jersey AIDS Alliance dba North Jersey Community Research Initiative (NJCRI)
NCT06316739
A Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic HCV
Atea Pharmaceuticals
NCT05904470
TD-6450 MAD Study in HCV Infected Subjects
Theravance Biopharma
NCT02116543
Long Term Extension Study is Designed to Monitor Long-Term Efficacy and Safety of Miravirsen Sodium in Combination With Telaprevir and Ribavirin in Subjects With Chronic Hepatitis C Virus Genotype 1 Infection
Hoffmann-La Roche
NCT02452814
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on HCV records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on HCV trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this HCV page
9 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 HCV trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- North Jersey AIDS Alliance dba North Jersey Community Research Initiative (NJCRI) sponsors the most HCV trials on record, review their full trial history before evaluating a specific study. See North Jersey AIDS Alliance dba North Jersey Community Research Initiative (NJCRI)'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This HCV condition card totals 9 registered trials; most-linked intervention TD-6450; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.